Jeevan Scientific Technology informs about company updates

21 Dec 2016 Evaluate

Jeevan Scientific Technology has informed that the Company’s Clinical Pharmacology Centre to conduct Bioavailability/Bioequivalence studies has been approved by the ‘Office of Drug Control General, India (DCGI)’ on 16-December-2016 for a period of Three years. This Centre having four independent clinics having a total capacity of 132 beds will facilitate end-to-end Bioequivalence studies by Jeevan Scientific Technology.

The above information is a part of company’s filings submitted to BSE.

Jeevan Scientific Share Price

50.20 0.63 (1.27%)
03-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
TCS 3707.35
Infosys 1405.90
HCL Tech. 1314.60
Wipro 443.95
Tech Mahindra 1245.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.